Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.

This advertisement has not loaded yet, but your article continues below.

Given the latest recruitment posting, Cartoon Network is eager to dive into its DC anime, but this project might not be tied to superheroes. The team at Warner Bros. Discovery wants to make a DC ...

Smile and keep emphatically blinking until they go away.

These drops have been specially developed for people who have presbyopia, an eye-related condition that affects those above ...

The Drugs Controller General of India (DCGI) has granted approval to Entod Pharmaceuticals’ innovative PresVu eye drops, ...

(RTTNews) - LENZ Therapeutics, Inc. (LENZ) Monday said that the Food and Drug Administration (FDA) has accepted the company's new drug application for LNZ100 for the treatment of presbyopia.

(RTTNews) - Corxel Pharmaceuticals and LENZ Therapeutics (LENZ) announced positive topline data from the Phase 3 JX07001 clinical trial of LNZ100 in patients with presbyopia in China. In this ...